These outcomes, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 assist the notion of focusing on ACKR3 as a singular way to modulate the opioid process, which could open new therapeutic avenues for opioid-similar Diseases. Disclaimer: The above is really https://cyriln157faq9.bloggazza.com/profile